BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1831641)

  • 21. [Effect of recombinant human erythropoietin on reduce of homologous blood transfusion in open heart surgery].
    Shinonaga M; Hayashi J; Shinada S; Nakazawa S; Fujita Y; Ueno M; Equchi S
    Kyobu Geka; 1990 Apr; 43(4):276-9. PubMed ID: 2352389
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical spectrum of iron overload, novel uses of iron chelators, and potential treatment of pediatric anemias with erythropoietin. Introduction.
    Cairo MS
    Am J Pediatr Hematol Oncol; 1990; 12(1):1-3. PubMed ID: 2178456
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of preoperative erythropoietin in scoliosis surgery.
    Roye DP; Rothstein P; Rickert JB; Verdisco L; Farcy JP
    Spine (Phila Pa 1976); 1992 Jun; 17(6 Suppl):S204-5. PubMed ID: 1631719
    [No Abstract]   [Full Text] [Related]  

  • 24. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
    Levine EA; Gould SA
    Surg Annu; 1993; 25 Pt 1():83-99. PubMed ID: 8416148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recombinant human erythropoietin (epoetin) and autologous blood transfusion in chronic hemodialysis. Apropos of 2 cases].
    Montagnac R; Ebikili B; Schillinger F
    Nephrologie; 1997; 18(1):23-6. PubMed ID: 9121601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant erythropoietin in autologous blood donation].
    von Bormann B; Weidler B; Friedrich M; von Andrian-Werburg H
    Anaesthesist; 1991 Jul; 40(7):386-90. PubMed ID: 1928712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Definition of a target population for utilization of recombinant erythropoietin with a view to taking of delayed autologous blood].
    Fournel JJ
    Nouv Rev Fr Hematol (1978); 1995; 37 Suppl 1():S27-36. PubMed ID: 7478982
    [No Abstract]   [Full Text] [Related]  

  • 28. Impact of autologous blood predonation on a comprehensive blood conservation program.
    Sandrelli L; Pardini A; Lorusso R; Sala ML; Licenziati M; Alfieri O
    Ann Thorac Surg; 1995 Mar; 59(3):730-5. PubMed ID: 7887720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recombinant human erythropoietin therapy in the surgical setting and applications in oncology.
    Goodnough LT
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):98-102. PubMed ID: 1928088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of preoperative treatment with recombinant human erythropoietin in patients undergoing hemodilutional autologous transfusion].
    Nakae Y; Sonoda H; Miyabe M; Kawamata M; Sakakibara N; Kawana S; Namiki A
    Masui; 1995 Oct; 44(10):1362-8. PubMed ID: 8538004
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recombinant erythropoietic growth factors as an alternative to erythrocyte transfusion for patients with "anemia of prematurity".
    Christensen RD
    Pediatrics; 1989 May; 83(5):793-6. PubMed ID: 2717299
    [No Abstract]   [Full Text] [Related]  

  • 32. [Blood extractions, transfusion policy and erythropoietin in the newborn].
    Figueras Aloy J; Carbonell Estrany X
    An Esp Pediatr; 1998 Jul; 49(1):46-8. PubMed ID: 9718766
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of anemia in chronically dialyzed patients].
    Moynot A
    Nephrologie; 1998; 19(3):125-7. PubMed ID: 9633055
    [No Abstract]   [Full Text] [Related]  

  • 34. [Should we include seropositive patients in autotransfusion programs?].
    Herranz Martí MJ; Peró Silva A
    Sangre (Barc); 1998 Aug; 43(4):317-20. PubMed ID: 9789997
    [No Abstract]   [Full Text] [Related]  

  • 35. An audit on the current practice of red blood cell transfusion following elective primary hip arthroplasty.
    Ozgönenel B; Kanhere R; O'Malley B; Balasubramaniam M; Eisenbrey AB
    Transfus Apher Sci; 2007 Aug; 37(1):9-16. PubMed ID: 17707695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical applications of recombinant human erythropoietin (rHu-EPO) in the field of urology].
    Katsuoka Y; Shibahara N
    Nihon Hinyokika Gakkai Zasshi; 1997 Dec; 88(12):969-83. PubMed ID: 9465596
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of recombinant human erythropoietin on anaemia after gastrectomy: a pilot study.
    Tsuji Y; Kambayashi J; Shiba E; Sakon M; Kawasaki T; Mori T
    Eur J Surg; 1995 Jan; 161(1):29-33. PubMed ID: 7727602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical application of recombinant erythropoietin in the perioperative period.
    Goodnough LT
    Hematol Oncol Clin North Am; 1994 Oct; 8(5):1011-20. PubMed ID: 7852209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Application and reality of erythrocyte transfusion].
    Yasukawa M
    Nihon Naika Gakkai Zasshi; 1996 Jun; 85(6):801-5. PubMed ID: 8753042
    [No Abstract]   [Full Text] [Related]  

  • 40. Indications for autotransfusion in surgical oncology.
    Mercuriali F; Inghilleri G
    Tumori; 2001; 87(2):S30-5. PubMed ID: 11401221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.